The identification of these protein hubs may reflect underlying pathways involved in dyslipidemia (OSBPL10), beige fat biogenesis (CUL2), fatty liver disease and insulin resistance (PRTN3) (31–33). This evidence concerns the gene PRTN3 and fatty liver disease.